2021 Q3 Form 10-Q Financial Statement
#000121390021058741 Filed on November 12, 2021
Income Statement
| Concept | 2021 Q3 |
|---|---|
| Revenue | $0.00 |
| YoY Change | |
| Cost Of Revenue | |
| YoY Change | |
| Gross Profit | |
| YoY Change | |
| Gross Profit Margin | |
| Selling, General & Admin | $210.9K |
| YoY Change | |
| % of Gross Profit | |
| Research & Development | |
| YoY Change | |
| % of Gross Profit | |
| Depreciation & Amortization | |
| YoY Change | |
| % of Gross Profit | |
| Operating Expenses | $295.8K |
| YoY Change | |
| Operating Profit | -$295.8K |
| YoY Change | |
| Interest Expense | $430.00 |
| YoY Change | |
| % of Operating Profit | |
| Other Income/Expense, Net | $974.0K |
| YoY Change | |
| Pretax Income | -$245.3K |
| YoY Change | |
| Income Tax | |
| % Of Pretax Income | |
| Net Earnings | -$245.3K |
| YoY Change | |
| Net Earnings / Revenue | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | -$32.87K |
| COMMON SHARES | |
| Basic Shares Outstanding | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2021 Q3 |
|---|---|
| SHORT-TERM ASSETS | |
| Cash & Short-Term Investments | $350.8K |
| YoY Change | |
| Cash & Equivalents | $350.8K |
| Short-Term Investments | |
| Other Short-Term Assets | $388.2K |
| YoY Change | |
| Inventory | |
| Prepaid Expenses | |
| Receivables | |
| Other Receivables | |
| Total Short-Term Assets | $739.0K |
| YoY Change | |
| LONG-TERM ASSETS | |
| Property, Plant & Equipment | |
| YoY Change | |
| Goodwill | |
| YoY Change | |
| Intangibles | |
| YoY Change | |
| Long-Term Investments | $57.34M |
| YoY Change | |
| Other Assets | |
| YoY Change | |
| Total Long-Term Assets | $57.34M |
| YoY Change | |
| TOTAL ASSETS | |
| Total Short-Term Assets | $739.0K |
| Total Long-Term Assets | $57.34M |
| Total Assets | $58.08M |
| YoY Change | |
| SHORT-TERM LIABILITIES | |
| YoY Change | |
| Accounts Payable | $142.5K |
| YoY Change | |
| Accrued Expenses | |
| YoY Change | |
| Deferred Revenue | |
| YoY Change | |
| Short-Term Debt | $0.00 |
| YoY Change | |
| Long-Term Debt Due | |
| YoY Change | |
| Total Short-Term Liabilities | $269.2K |
| YoY Change | |
| LONG-TERM LIABILITIES | |
| Long-Term Debt | $0.00 |
| YoY Change | |
| Other Long-Term Liabilities | $1.500M |
| YoY Change | |
| Total Long-Term Liabilities | $1.500M |
| YoY Change | |
| TOTAL LIABILITIES | |
| Total Short-Term Liabilities | $269.2K |
| Total Long-Term Liabilities | $1.500M |
| Total Liabilities | $1.769M |
| YoY Change | |
| SHAREHOLDERS EQUITY | |
| Retained Earnings | |
| YoY Change | |
| Common Stock | |
| YoY Change | |
| Preferred Stock | |
| YoY Change | |
| Treasury Stock (at cost) | |
| YoY Change | |
| Treasury Stock Shares | |
| Shareholders Equity | $56.31M |
| YoY Change | |
| Total Liabilities & Shareholders Equity | $58.08M |
| YoY Change |
Cashflow Statement
| Concept | 2021 Q3 |
|---|---|
| OPERATING ACTIVITIES | |
| Net Income | -$245.3K |
| YoY Change | |
| Depreciation, Depletion And Amortization | |
| YoY Change | |
| Cash From Operating Activities | -$389.6K |
| YoY Change | |
| INVESTING ACTIVITIES | |
| Capital Expenditures | |
| YoY Change | |
| Acquisitions | |
| YoY Change | |
| Other Investing Activities | -$57.34M |
| YoY Change | |
| Cash From Investing Activities | -$57.34M |
| YoY Change | |
| FINANCING ACTIVITIES | |
| Cash Dividend Paid | |
| YoY Change | |
| Common Stock Issuance & Retirement, Net | |
| YoY Change | |
| Debt Paid & Issued, Net | |
| YoY Change | |
| Cash From Financing Activities | 57.96M |
| YoY Change | |
| NET CHANGE | |
| Cash From Operating Activities | -389.6K |
| Cash From Investing Activities | -57.34M |
| Cash From Financing Activities | 57.96M |
| Net Change In Cash | 233.8K |
| YoY Change | |
| FREE CASH FLOW | |
| Cash From Operating Activities | -$389.6K |
| Capital Expenditures | |
| Free Cash Flow | |
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001854583 | ||
| CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2021Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1728078 | shares |
| CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | ||
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
USD | |
| CY2021Q3 | aspa |
Sale Of5733920 Units Net Of Underwriting Discounts And Offering Costs
SaleOf5733920UnitsNetOfUnderwritingDiscountsAndOfferingCosts
|
USD | |
| CY2021Q1 | us-gaap |
Cash
Cash
|
USD |
